2025
SJR Q2
JCR Q2 · 2,1
OA
SCIE
Journal detail
Indian Journal of Medical Research
- Publisher
- Scientific Scholar LLC
- Country
- United States · Northern America
- Type
- journal
- ISSN
-
09715916
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,605
- Quartile Q2
- H-Index 116
- Cites/doc 1,6
- Docs (3y) 546
- Cites (3y) 1.183
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 2,1
- 5Y JIF 3,3
- JCI 0,41
WoS indexes
- SCIE
Subject classification
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q2 | 0,605 | 2,1 | 3,3 | 0,41 | Q2 | 116 |
| 2024 | Q2 | Q1 | 0,61 | 2,5 | 3,4 | 0,41 | Q2 | 110 |
| 2023 | Q2 | Q1 | 0,586 | 2,7 | 3,6 | 0,55 | Q2 | 110 |
| 2022 | Q2 | Q2 | 0,716 | 4,2 | 3,5 | 0,58 | Q2 | 110 |
| 2021 | Q1 | Q2 | 0,907 | 5,3 | 3,9 | 0,63 | Q2 | 110 |
| 2020 | Q2 | Q3 | 0,578 | 2,4 | 2,6 | 0,37 | Q2 | 110 |
| 2019 | Q2 | Q3 | 0,507 | 1,5 | 2 | 0,35 | Q2 | 110 |
| 2018 | — | Q3 | — | 1,3 | 2 | 0,39 | Q2 | — |
| 2017 | Q2 | Q3 | 0,656 | 1,5 | 2 | 0,43 | Q2 | 110 |
| 2016 | Q2 | Q2 | 0,824 | 1,5 | 2,2 | — | — | 110 |
| 2015 | Q2 | Q2 | 0,729 | 1,4 | 2 | — | — | 110 |
| 2014 | Q2 | Q2 | 0,79 | 1,4 | 1,9 | — | — | 110 |
| 2013 | Q2 | Q2 | 0,666 | 1,7 | 2 | — | — | 110 |
| 2012 | Q2 | Q2 | 0,589 | 2,1 | 2,3 | — | — | 110 |
| 2011 | Q2 | Q2 | 0,647 | 1,8 | 2,2 | — | — | 110 |
| 2010 | Q2 | Q2 | 0,628 | 1,8 | 2,1 | — | — | 110 |
| 2009 | — | Q2 | — | 1,5 | 1,9 | — | — | — |
| 2008 | — | Q2 | — | 1,9 | 1,8 | — | — | — |
| 2007 | — | Q2 | — | 1,7 | 1,5 | — | — | — |
| 2006 | — | Q2 | — | 1,2 | — | — | — | — |
| 2005 | — | Q3 | — | 0,9 | — | — | — | — |
| 2004 | — | Q3 | — | 0,6 | — | — | — | — |
| 2003 | — | Q3 | — | 0,5 | — | — | — | — |
| 2002 | — | Q3 | — | 0,4 | — | — | — | — |
| 2001 | — | Q3 | — | 0,3 | — | — | — | — |
| 2000 | — | Q3 | — | 0,4 | — | — | — | — |
| 1999 | — | Q3 | — | 0,4 | — | — | — | — |
| 1998 | — | Q3 | — | 0,4 | — | — | — | — |
| 1997 | — | Q3 | — | 0,3 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | IMMUNOLOGY | SCIE | Q4 | Q4 | 142/183 |
| 2025 | MEDICINE, GENERAL & INTERNAL | SCIE | Q2 | Q2 | 107/336 |
| 2025 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | Q3 | 121/191 |
| 2024 | IMMUNOLOGY | SCIE | Q3 | Q4 | 122/183 |
| 2024 | MEDICINE, GENERAL & INTERNAL | SCIE | Q1 | Q2 | 74/332 |
| 2024 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | Q3 | 102/195 |
| 2023 | IMMUNOLOGY | SCIE | Q3 | Q3 | 120/181 |
| 2023 | MEDICINE, GENERAL & INTERNAL | SCIE | Q1 | Q2 | 68/329 |
| 2023 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | Q3 | 95/189 |
| 2022 | IMMUNOLOGY | SCIE | Q3 | Q3 | 87/161 |
| 2022 | MEDICINE, GENERAL & INTERNAL | SCIE | Q2 | Q2 | 54/169 |
| 2022 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q3 | 63/136 |
| 2021 | IMMUNOLOGY | SCIE | Q2 | Q3 | 69/162 |
| 2021 | MEDICINE, GENERAL & INTERNAL | SCIE | Q2 | Q2 | 51/172 |
| 2021 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q2 | Q3 | 55/139 |
| 2020 | IMMUNOLOGY | SCIE | Q4 | Q4 | 133/162 |
| 2020 | MEDICINE, GENERAL & INTERNAL | SCIE | Q3 | Q2 | 85/167 |
| 2020 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | Q4 | 106/140 |
| 2019 | IMMUNOLOGY | SCIE | Q4 | Q4 | 142/159 |
| 2019 | MEDICINE, GENERAL & INTERNAL | SCIE | Q3 | Q2 | 93/165 |
| 2019 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | Q4 | 114/139 |
| 2018 | IMMUNOLOGY | SCIE | Q4 | Q4 | 144/158 |
| 2018 | MEDICINE, GENERAL & INTERNAL | SCIE | Q3 | Q2 | 92/160 |
| 2018 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | Q3 | 115/136 |
| 2017 | IMMUNOLOGY | SCIE | Q4 | Q4 | 138/155 |
| 2017 | MEDICINE, GENERAL & INTERNAL | SCIE | Q3 | Q2 | 79/155 |
| 2017 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | Q3 | 103/133 |
| 2016 | IMMUNOLOGY | SCIE | Q4 | — | 130/151 |
| 2016 | MEDICINE, GENERAL & INTERNAL | SCIE | Q2 | — | 71/155 |
| 2016 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 92/128 |
| 2015 | IMMUNOLOGY | SCIE | Q4 | — | 136/151 |
| 2015 | MEDICINE, GENERAL & INTERNAL | SCIE | Q2 | — | 70/155 |
| 2015 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 90/124 |
| 2014 | IMMUNOLOGY | SCIE | Q4 | — | 130/148 |
| 2014 | MEDICINE, GENERAL & INTERNAL | SCIE | Q2 | — | 70/154 |
| 2014 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | — | 93/123 |
| 2013 | IMMUNOLOGY | SCIE | Q4 | — | 123/144 |
| 2013 | MEDICINE, GENERAL & INTERNAL | SCIE | Q2 | — | 59/156 |
| 2013 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 80/124 |
| 2012 | IMMUNOLOGY | SCIE | Q3 | — | 101/137 |
| 2012 | MEDICINE, GENERAL & INTERNAL | SCIE | Q2 | — | 39/155 |
| 2012 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 70/121 |
| 2011 | IMMUNOLOGY | SCIE | Q4 | — | 111/139 |
| 2011 | MEDICINE, GENERAL & INTERNAL | SCIE | Q2 | — | 51/155 |
| 2011 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 67/112 |
| 2010 | IMMUNOLOGY | SCIE | Q4 | — | 106/134 |
| 2010 | MEDICINE, GENERAL & INTERNAL | SCIE | Q2 | — | 44/153 |
| 2010 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 56/106 |
| 2009 | IMMUNOLOGY | SCIE | Q4 | — | 109/128 |
| 2009 | MEDICINE, GENERAL & INTERNAL | SCIE | Q2 | — | 49/133 |
| 2009 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 61/93 |
| 2008 | IMMUNOLOGY | SCIE | Q4 | — | 91/121 |
| 2008 | MEDICINE, GENERAL & INTERNAL | SCIE | Q2 | — | 42/107 |
| 2008 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 48/83 |
| 2007 | IMMUNOLOGY | SCIE | Q4 | — | 92/119 |
| 2007 | MEDICINE, GENERAL & INTERNAL | SCIE | Q2 | — | 36/100 |
| 2007 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 47/81 |
| 2006 | IMMUNOLOGY | SCIE | Q4 | — | 100/117 |
| 2006 | MEDICINE, GENERAL & INTERNAL | SCIE | Q2 | — | 51/103 |
| 2006 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 53/76 |
| 2005 | IMMUNOLOGY | SCIE | Q4 | — | 102/115 |
| 2005 | MEDICINE, GENERAL & INTERNAL | SCIE | Q3 | — | 58/105 |
| 2005 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | — | 59/72 |
| 2004 | IMMUNOLOGY | SCIE | Q4 | — | 102/111 |
| 2004 | MEDICINE, GENERAL & INTERNAL | SCIE | Q3 | — | 65/103 |
| 2004 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | — | 62/71 |
| 2003 | IMMUNOLOGY | SCIE | Q4 | — | 108/114 |
| 2003 | MEDICINE, GENERAL & INTERNAL | SCIE | Q3 | — | 71/102 |
| 2003 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | — | 65/72 |
| 2002 | IMMUNOLOGY | SCIE | Q4 | — | 112/119 |
| 2002 | MEDICINE, GENERAL & INTERNAL | SCIE | Q3 | — | 74/107 |
| 2002 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | — | 71/74 |
| 2001 | IMMUNOLOGY | SCIE | Q4 | — | 110/114 |
| 2001 | MEDICINE, GENERAL & INTERNAL | SCIE | Q3 | — | 80/112 |
| 2001 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | — | 69/75 |
| 2000 | IMMUNOLOGY | SCIE | Q4 | — | 112/116 |
| 2000 | MEDICINE, GENERAL & INTERNAL | SCIE | Q3 | — | 70/105 |
| 2000 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | — | 66/74 |
| 1999 | IMMUNOLOGY | SCIE | Q4 | — | 106/115 |
| 1999 | MEDICINE, GENERAL & INTERNAL | SCIE | Q3 | — | 74/110 |
| 1999 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | — | 69/76 |
| 1998 | IMMUNOLOGY | SCIE | Q4 | — | 108/120 |
| 1998 | MEDICINE, GENERAL & INTERNAL | SCIE | Q3 | — | 61/107 |
| 1998 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q3 | — | 54/72 |
| 1997 | IMMUNOLOGY | SCIE | Q4 | — | 108/117 |
| 1997 | MEDICINE, GENERAL & INTERNAL | SCIE | Q3 | — | 70/100 |
| 1997 | MEDICINE, RESEARCH & EXPERIMENTAL | SCIE | Q4 | — | 55/61 |